Ask a doctor about a prescription for TIORFAN NIÑOS 30 mg ORAL SUSPENSION GRANULES
Leaflet: information for the user
Tiorfan Children 30 mg granules for oral suspension
racecadotril
Read the entire leaflet carefully before starting to take the medicine.
Contents of the leaflet:
Tiorfan is a medicine for the treatment of diarrhea.
Tiorfan is used to treat the symptoms of acute diarrhea in children over 3 months. It should be used in conjunction with abundant fluid intake and usual dietary measures, when these measures alone are insufficient to control diarrhea, and when the causes of diarrhea cannot be treated.
If causal treatment is possible, racecadotril may be administered as complementary treatment.
Do not use Tiorfan
Warnings and precautions
Consult your doctor or pharmacist before starting to give Tiorfan to your child if:
Racecadotril, the active ingredient of Tiorfan, may cause an allergic reaction called angioedema, which can cause swelling of the face, lips, throat, or tongue. If your child experiences these side effects, stop treatment immediately and contact your doctor. Swelling can occur at any time during treatment with this product.
The concomitant use of this product and some other medicines may increase the risk of angioedema (see "Other medicines and Tiorfan").
Skin reactions have been reported with the use of this product. In most cases, they are mild and do not require treatment. In some cases, severe skin reactions may occur. In these cases, treatment should be stopped immediately and the child should not be treated with racecadotril again.
Severe skin reactions, including drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported in association with treatment with racecadotril. Discontinue the use of racecadotril and seek immediate medical attention if you notice any of the symptoms related to these severe skin reactions described in section 4.
Using Tiorfan with other medicines
Tell your doctor if your child is using, has recently used, or may need to use any other medicine.
Especially tell your doctor if your child is using any of the following medicines, as they may increase the risk of side effects (see "Warnings and precautions"):
Pregnancy and breastfeeding
The use of Tiorfan is not recommended during pregnancy and breastfeeding.
Consult your doctor or pharmacist before using this medicine.
Driving and using machines
Tiorfan has little or no effect on the ability to drive or operate machinery.
Tiorfan contains sucrose
Tiorfan contains approximately 3 g of sucrose per sachet.
If your doctor has told you that your child has intolerance to some sugars, ask your doctor before giving Tiorfan to your child.
In children with diabetes, the amount of sucrose ingested with Tiorfan should be taken into account in the child's total daily sugar intake.
Follow the instructions for administering Tiorfan indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Tiorfan is presented in the form of granules.
The granules can be added to food or mixed in a glass of water or in the baby bottle. Mix well and give it to your child immediately.
The recommended daily dose depends on your child's weight: 1.5 mg/kg per dose (corresponding to 1-2 sachets), three times a day at regular intervals.
In children weighing 13 to 27 kg: one sachet per dose.
In children weighing over 27 kg: approximately two sachets per dose.
Your doctor will indicate the duration of treatment with Tiorfan. Treatment should be continued until two normal stools are produced, without exceeding 7 days.
To compensate for the loss of fluid due to your child's diarrhea, this medicine should be used in conjunction with adequate fluid and electrolyte replacement. The best replacement of fluids and salts is achieved with an oral rehydration solution (please ask your doctor or pharmacist if you are not sure).
If you give more Tiorfan than you should
If your child has taken more Tiorfan than they should, contact your doctor or pharmacist immediately.
If you forget to give Tiorfan
Do not give your child a double dose to make up for a forgotten dose. Simply continue with the treatment.
Like all medicines, this medicine can cause side effects, although not everyone gets them.
Stop administering Tiorfan to your child and contact a doctor immediately if your child experiences symptoms of angioedema, such as:
Discontinue the use of racecadotril and seek immediate medical attention if you notice any of the following symptoms:
The following side effects have been reported:
Uncommon (may affect up to 1 in 100 people): tonsillitis (inflammation of the tonsils), rash, and erythema (redness of the skin).
Frequency not known (frequency cannot be estimated from available data):
erythema multiforme (red lesions on the extremities and inside the mouth), tongue swelling, facial swelling, lip swelling, eyelid swelling, urticaria, erythema nodosum (inflammation in the form of lumps under the skin), papular rash (rash on the skin with small, hard, and raised lesions), prurigo (lesions on the skin with itching), and pruritus (generalized itching).
Reporting side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are possible side effects not listed in this leaflet. You can also report them directly through the Spanish Medicines Agency's website (www.notificaram.es). By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the sachet and carton after EXP. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Tiorfan
The active substance is racecadotril. Each sachet contains 30 mg of racecadotril.
The other ingredients are:
sucrose,
colloidal anhydrous silica,
30% polyacrylate dispersion,
apricot flavor.
Appearance of Tiorfan and package contents
Tiorfan is presented in the form of granules for oral suspension in sachets.
Each pack contains 10, 16, 20, 30, 50, or 100 sachets (100 sachets only as a clinical pack).
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
BIOPROJET-FERRER, S.L.
Gran Vía Carlos III, 94
08028 Barcelona (Spain)
Manufacturer
FERRER INTERNACIONAL, S.A.
Joan Buscallà 1-9
08173 Sant Cugat del Vallès, Barcelona (Spain)
or
SOPHARTEX,
21 rue de Pressoir,
28500 Vernouillet (France)
This medicine is authorized in the Member States of the European Economic Area under the following names:
GERMANY: Tiorfan
PORTUGAL: Tiorfan
GREECE: Hidrasec
ITALY: Tiorfix
AUSTRIA: Hidrasec
BELGIUM: Tiorfast
CZECH REPUBLIC: Hidrasec
DENMARK: Hidrasec
ESTONIA: Hidrasec
FINLAND: Hidrasec
HUNGARY: Hidrasec
IRELAND: Hidrasec
LATVIA: Hidrasec
LITHUANIA: Hidrasec
LUXEMBOURG: Tiorfast
NETHERLANDS: Tiorfan
POLAND: Hidrasec
SLOVAKIA: Hidrasec
SLOVENIA: Hidrasec
SWEDEN: Hidrasec
UNITED KINGDOM: Hidrasec
Date of the last revision of this leaflet 24-11-2024
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) www.aemps.gob.es.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for TIORFAN NIÑOS 30 mg ORAL SUSPENSION GRANULES – subject to medical assessment and local rules.